Well Lead Medical (Well Lead) in China has awarded a new contract to Bactiguard, a Sweden-based meditech company.
It was reported on Friday that the order is to generate revenues of around SEK16.5m in the fourth quarter of 2019.
Christian Kinch, CEO, stated: "This is the second order from Well Lead outside the initial contract and further strengthens that end-customer sales in China are picking up. At the same, we don't expect to receive any new orders from Well Lead in the beginning of next year, given the high volumes delivered in the third and fourth quarters of this year."
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access